The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|2|139-145

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.2, 2002-01, pp. : 139-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3739-3759

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1035-1048

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT 1B/D Receptor Antagonists

By Pauwels P.J.  

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 293-303

Elsevier

Access to resources Recommend Favorite

Recent Advances in 5-HT1B / 1D Receptor Antagonists and Agonists and their Potential Therapeutic Applications

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 6, 2002-06 ,pp. : 559-574

Bentham Science Publishers

Access to resources Recommend Favorite